Quantbot Technologies’s Odonate Therapeutics ODT Stock Holding History
Bought
Maintained
Sold
Other funds holding ODT
Quantbot Technologies's ODT Position: Q4 2021 in Review
Quantbot Technologies sold out of Odonate Therapeutics (ODT) in Q4 2021, closing a stake of 2,300 shares — an estimated $6K sold.
Quantbot Technologies first reported a position in ODT in Q3 2020 and held it in 2 quarters. The position peaked at $6K in Q3 2021. 50 funds tracked by Wall St. Rank hold ODT as of Q4 2021.
- Quantbot Technologies reported no remaining Odonate Therapeutics position as of Q4 2021 after selling out during the quarter.
- Quantbot Technologies sold 2,300 Odonate Therapeutics shares in Q4 2021, an estimated $6K.
- Quantbot Technologies first reported a position in Odonate Therapeutics in Q3 2020 and held it in 2 quarters.
- Quantbot Technologies's Odonate Therapeutics position peaked at $6K in Q3 2021.
- 50 funds tracked by Wall St. Rank held Odonate Therapeutics as of Q4 2021.
Based on Quantbot Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.